As recently discussed at the European Society of Medical Oncology (ESMO) Virtual Congress 2020, the COVID-19 pandemic has resulted in delays and/or cancellation of cancer treats, while increasing stress levels and causing burnout among oncologists. According to a statement by Dr. Guy Jerusalem at the Centre Hospitalier Universitaire Sart Tilman in Belgium, "COVID-19 has had a major impact on the organization of patient care...there is a risk that the diagnosis of new cancer cases will be delayed and that more patients will be diagnosed at a later stage of their disease." Studying findings indicated that among survey results obtained from cancer centres across 18 European countries, 60.9% admitted that clinical activity was reduced as a result of COVID-19, with 64.2% concerned about under-treatment, and 37% expecting significant reductions in clinical trials.
To read more about this study, click here.
No comments:
Post a Comment